We began our study of the role of BLT2 in KRAS-mutant lung cancer by examining the basal expression levels of BLT2, 5-LOX, and 12-LOX in KRAS-mutant lung cancer cells. This evidence concerns the gene ALOX5 and lung carcinoma.